American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Manufacturer Recalls Alcohol Prep Pads, Swabs, Swabsticks

Products May be Contaminated With Bacillus Cereus

By News Staff

The Triad Group is recalling all lots of its alcohol prep pads, swabs and swabsticks, which are used to disinfect skin prior to injections or IV insertion. These products could expose patients to the pathogen Bacillus cereus.
Product Recall
The FDA said in a Jan. 6 safety alert that use of contaminated products could lead to life-threatening infections, especially in at-risk populations, including immunosuppressed and surgical patients.

The Triad Group said in a Jan. 5 news release that it had received one report of a skin infection that was not-life threatening. The Hartland, Wis.-based manufacturer responded by recalling all lots of its alcohol prep pads, swabs and swabsticks.

"We are, out of an abundance of caution, recalling these lots to ensure that we are not the source of these contamination issues," the company said.

The recalled products are manufactured by Triad but have been sold as private-label OTC products and distributed nationwide to hospital and retail pharmacies. The products, which also were manufactured for and distributed to several wholesale customers, may use the following names in their packaging:
  • Cardinal Health,
  • PSS Select,
  • VersaPro,
  • Boca/Ultilet,
  • Moore Medical,
  • Walgreens,
  • CVS and
  • Conzellin.
In all, more than three dozen brand-name products are affected, according to a recall fact sheet (1-page PDF; About PDFs) posted on Triad's website.

Consumers are advised to not use the recalled products, which should be returned to the place they were purchased for a full refund, Triad said. Additional questions may be directed to Triad Group Customer Service at (800) 288-1288.

Physicians and patients should report adverse events or side effects related to the use of these products to the FDA's MedWatch program.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control